title: Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats.
abstract: Dopamine and dopamine-receptor function are often implicated in behavioral inhibition, and deficiencies within behavioral inhibition processes linked to attention deficit/hyperactivity disorder (ADHD), schizophrenia, obsessive-compulsive disorder, and drug addiction. In the stop-signal task, which measures the speed of the process of inhibition [stop-signal reaction time (SSRT)], psychostimulant-related improvement of SSRT in ADHD is linked with dopamine function. However, the precise nature of dopaminergic control over SSRT remains unclear. This study examined region- and receptor-specific modulation of SSRT in the rat using direct infusions of the dopamine D1 receptor (DRD1) antagonist SCH 23390 or dopamine D2 receptor (DRD2) antagonist sulpiride into the dorsomedial striatum (DMStr) or nucleus accumbens core (NAcbC). DRD1 and DRD2 antagonists had contrasting effects on SSRT that were specific to the DMStr. SCH 23390 decreased SSRT with little effect on the go response. Conversely, sulpiride increased SSRT but also increased go-trial reaction time and reduced trial completion at the highest doses. These results suggest that DRD1 and DRD2 function within the DMStr, but not the NAcbC, may act to balance behavioral inhibition in a manner that is independent of behavioral activation.
authors: Behavioral and Clinical Neuroscience Institute and Department of Experimental Psychology, University of Cambridge, Cambridge CB2 3EB, United Kingdom. de102@cam.ac.uk
authors: Dawn M
authors: DM
authors: Eagle
authors: Jacky C K
authors: JC
authors: Wong
authors: Michelle E
authors: ME
authors: Allan
authors: Adam C
authors: AC
authors: Mar
authors: David E
authors: DE
authors: Theobald
authors: Trevor W
authors: TW
authors: Robbins
references: Trends Neurosci. 1990 Jul;13(7):281-5
references: 1695404
references: Psychopharmacology (Berl). 2007 Apr;191(3):587-98
references: 16972104
references: Behav Brain Res. 2003 Nov 30;146(1-2):131-44
references: 14643466
references: J Neurosci. 2006 Mar 1;26(9):2424-33
references: 16510720
references: Science. 2007 Mar 2;315(5816):1267-70
references: 17332411
references: Neuropsychopharmacology. 2007 Feb;32(2):273-83
references: 16641946
references: J Neurophysiol. 2000 Jul;84(1):289-300
references: 10899204
references: Psychopharmacology (Berl). 2007 Jun;192(2):193-206
references: 17277934
references: Biol Psychiatry. 2006 May 15;59(10):898-907
references: 16682268
references: Neuropsychopharmacology. 2001 Oct;25(4):514-26
references: 11557165
references: Neuropsychopharmacology. 2010 Feb;35(3):591-604
references: 19940844
references: J Abnorm Child Psychol. 1989 Oct;17(5):473-91
references: 2681316
references: J Neurosci. 2009 Aug 12;29(32):10171-9
references: 19675251
references: Behav Res Methods. 2010 Nov;42(4):1059-71
references: 21139173
references: Psychol Rev. 2014 Jan;121(1):66-95
references: 24490789
references: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3125-35
references: 18640910
references: Science. 2001 Jun 29;292(5526):2499-501
references: 11375482
references: Neurosci Biobehav Rev. 2010 Jul;34(8):1161-77
references: 20105440
references: Exp Clin Psychopharmacol. 2009 Dec;17(6):374-83
references: 19968402
references: Nat Rev Neurosci. 2009 Dec;10(12):885-92
references: 19904278
references: Psychopharmacology (Berl). 2006 Jul;187(1):73-85
references: 16767417
references: Trends Neurosci. 2004 Aug;27(8):468-74
references: 15271494
references: Neurosci Biobehav Rev. 2009 May;33(5):631-46
references: 18835296
references: J Neurosci. 2010 Jun 30;30(26):8888-96
references: 20592211
references: Behav Brain Res. 2003 Oct 17;145(1-2):7-15
references: 14529800
references: Cogn Affect Behav Neurosci. 2008 Dec;8(4):485-97
references: 19033243
references: J Neurosci. 2007 Oct 31;27(44):11860-4
references: 17978025
references: Behav Neurosci. 2000 Aug;114(4):830-7
references: 10959541
references: J Neurosci. 2009 Nov 25;29(47):14734-40
references: 19940168
references: Neurosci Res. 2002 Jun;43(2):111-7
references: 12067746
references: JAMA. 2009 Sep 9;302(10):1084-91
references: 19738093
references: Neuropsychopharmacology. 2010 Jan;35(1):217-38
references: 19710631
references: Behav Neurosci. 2003 Dec;117(6):1302-17
references: 14674849
references: J Neurosci Methods. 1980 Dec;3(2):129-49
references: 6110810
references: Neurosci Biobehav Rev. 2004 Nov;28(7):771-84
references: 15555683
references: Neurosci Biobehav Rev. 2010 Jan;34(1):50-72
references: 19615404
references: Biol Psychiatry. 2011 Jun 15;69(12):e55-68
references: 20932513
references: Behav Neurosci. 2000 Aug;114(4):838-848
references: 10959542
references: Neurosci Lett. 2008 Feb 13;432(1):40-5
references: 18248891
references: Psychopharmacology (Berl). 2009 Aug;205(2):273-83
references: 19404616
references: Trends Neurosci. 1990 Jul;13(7):266-71
references: 1695401
references: Neuroscientist. 2007 Jun;13(3):214-28
references: 17519365
references: J Neurosci. 2004 Jan 28;24(4):773-80
references: 14749421
references: Neuroimage. 2008 Jul 15;41(4):1352-63
references: 18485743
references: Behav Neurosci. 2006 Jun;120(3):497-517
references: 16768602
references: Neuroimage. 2010 Oct 1;52(4):1621-32
references: 20452445
references: Synapse. 1993 Jun;14(2):169-77
references: 8101394
references: Neuropsychopharmacology. 2007 Jul;32(7):1583-99
references: 17164816
references: Brain. 1998 Jul;121 ( Pt 7):1343-55
references: 9679785
references: Cereb Cortex. 2008 Jan;18(1):178-88
references: 17517682